Evidence map›Paper›PMID 35273645›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2022

Harnessing the Natural Toxic Metabolites in COVID-19.

Ali Bahrami, Mohammad Taheri, Mohammad Reza Arabestani, Meysam Soleimani, Mojdeh Mohammadi, Fatemeh Golabchi, Maryam Banitorfi, Seyed Mostafa Hosseini, Sodabe Khodabandehlou, Fatemeh Nouri

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ali BahramiStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0002-7912-5505
Mohammad TaheriDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0003-4128-8613
Mohammad Reza ArabestaniDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0001-9991-8193
Meysam SoleimaniDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Scienceaffs, Hamadan, Iran.ORCID https://orcid.org/0000-0003-2505-8834
Mojdeh MohammadiDepartment of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0002-3957-2781
Fatemeh GolabchiStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Maryam BanitorfiStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Seyed Mostafa HosseiniDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0003-2604-504X
Sodabe KhodabandehlouDepartment of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Fatemeh NouriDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Scienceaffs, Hamadan, Iran.ORCID https://orcid.org/0000-0002-5315-8923
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped

Identifiers

PMID35273645
PMCPMC8902635
OpenAlexW4220676967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.